Importantly, we observed a positive correlation between the expression levels of Rap2B and plectin in CRC tissues, with higher levels of Rap2B and plectin predicting increased metastatic potential and poorer prognostic outcomes in CRC patients. The gene discussed is PLEC; the disease is colorectal carcinoma.